Nationwide Children's News Releases
Viewing: 121-130 of 1782 | All
Jun 27, 2023
Rapid Assessment Model Developed During Measles Outbreak to Quantify Immunity Gap
(COLUMBUS, Ohio) – In a study published today in The Lancet Regional Health – Americas, Rosemary Martoma, MD, academic pediatrician at Nationwide Children’s Hospital and lead author, describes VaxEstim, a novel statistical model developed to rapidly assess the vaccination coverage
Jun 26, 2023
Study Shows Unsafe Storage of Firearms Continues to Put Guns in the Hands of Children
(COLUMBUS, Ohio) – Firearms are the leading cause of death among children and teens 1-19 years old in the United States. According to new research from Nationwide Children’s Hospital, most unintentional firearm fatalities in which a child shoots another child involve boys, occur in the
Jun 22, 2023
FDA Approves First Gene Therapy Treatment for Duchenne Muscular Dystrophy Developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital
Today, the Abigail Wexner Research Institute at Nationwide Children’s Hospital praised the Food and Drug Administration (FDA) for its accelerated approval of SRP-9001/ELEVIDYS for Duchenne muscular dystrophy (DMD) following decades of research in its Center for Gene Therapy to help patients with neuromuscular diseases.
Jun 21, 2023
Nationwide Children’s Hospital Marks A Decade as One of the Nation’s Best
Nationwide Children’s Hospital has been named to U.S. News & World Report’s Best Children’s Hospitals Honor Roll for the 10th consecutive year. The Honor Roll is a top distinction awarded to only 10 children’s hospitals nationwide recognized by U.S. News as the “Best of the Best.” Nationwide Children’s is ranked sixth on the 2023-24 Honor Roll list.
Jun 13, 2023
Mapping the 3D Structure of Rhabdomyosarcoma Chromatin
In a paper published in Nucleic Acids Research Cancer (NAR Cancer), researchers from the Center for Childhood Cancer Research at Nationwide Children’s and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of rhabdomyosarcoma (RMS).
Jun 05, 2023
Nelson Weichold Named Chief Financial Officer at Nationwide Children’s
Nelson Weichold, MHA, has been named chief financial officer at Nationwide Children’s Hospital, effective June 5.
May 30, 2023
Ohio Governor Mike DeWine Supports The On Our Sleeves® Movement For Children’s Mental Health by Recognizing May 31 as Conversations With Kids Day
(COLUMBUS, Ohio) – In honor of national Mental Health Awareness Month, The On Our Sleeves Movement For Children’s Mental Health and Nationwide Children’s Hospital announce Ohio Governor Mike DeWine has issued a proclamation recognizing Wednesday, May 31, 2023 as Conversations With
May 19, 2023
Nationwide Children’s Hospital Becomes Certified Site for Gene Therapy for Transfusion-Dependent Beta Thalassemia
Nationwide Children’s Hospital has been designated a qualified treatment center for Zynteglo® (betibeglogene autotemcel), a a gene therapy approved for the treatment of people with beta thalassemia who require regular red blood cell transfusions.
May 18, 2023
The On Our Sleeves® Movement For Children’s Mental Health Names Dr. Ariana Hoet as Executive Clinical Director and Dr. Whitney Raglin Bignall as Associate Clinical Director
Nationwide Children’s Hospital announces Ariana Hoet, PhD, as the new executive clinical director of The On Our Sleeves Movement For Children’s Mental Health and Whitney J. Raglin Bignall, PhD, as the new associate clinical director of On Our Sleeves.
May 11, 2023
1 Year In, the CCDI Molecular Characterization Initiative Has Analyzed Samples From Over 1,000 Patients
The CCDI Molecular Characterization Initiative (MCI) is a project that aims to collect, analyze and report clinical and molecular data and is currently supporting Children’s Oncology Group (COG)-affiliated clinicians in choosing the best treatment for each child through precision diagnosis. This program is part of the National Cancer Institute (NCI) Childhood Cancer Data Initiative (CCDI), a national commitment and community-wide effort to harness data in ways that speed up progress in childhood cancer. Announced last year, the MCI is a collaboration among NCI, part of the National Institutes of Health, COG and Nationwide Children’s Hospital and is the largest initiative of its kind in the United States.